687 related articles for article (PubMed ID: 33628816)
21. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
[TBL] [Abstract][Full Text] [Related]
23. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract][Full Text] [Related]
24. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
[TBL] [Abstract][Full Text] [Related]
25. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma.
Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L
J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284
[TBL] [Abstract][Full Text] [Related]
26. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
27. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
[TBL] [Abstract][Full Text] [Related]
28. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
[TBL] [Abstract][Full Text] [Related]
29. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Jin Y; Qin X
DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
[TBL] [Abstract][Full Text] [Related]
31. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
32. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
[TBL] [Abstract][Full Text] [Related]
33. Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Jiang Y; Li Y; Ge H; Wu Y; Zhang Y; Guo S; Zhang P; Cheng J; Wang Y
J Oral Pathol Med; 2021 Nov; 50(10):1040-1049. PubMed ID: 34358365
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
35. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma.
Liu G; Zheng J; Zhuang L; Lv Y; Zhu G; Pi L; Wang J; Chen C; Li Z; Liu J; Chen L; Cai G; Zhang X
Sci Rep; 2018 Oct; 8(1):15250. PubMed ID: 30323196
[TBL] [Abstract][Full Text] [Related]
36. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.
Wang J; Bian Q; Liu J; Moming A
Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
38. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
39. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
40. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
